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 Abstract 
 
Microglia cells are specialized macrophages, found throughout the brain and spinal cord. 
Two functional distinct populations have been characterized on the basis of the expression of 
an antibody (5D4) reactive keratan sulfate proteoglycan on their cell surface. Cells with lower 
expression (5D4low) are more immunologically active than their highly expressing (5D4high) 
counterparts. 5D4high/5D4low- comparative microarray data revealed many differentially 
expressed genes which were of particular interest with respect to microglia development and 
function. Five genes, which showed an increased expression rate in 5D4high microglia cells, 
were analyzed: Cadm1, Dlx2, Dscam, Tef and Twist-2. All of them, besides Cadm1, were 
found to be active on the mRNA level in rat microglia cells. 
The role of Dscam in the immune system of Drosophila and its ability to make homo- and 
heterophilic interactions was very interesting in this aspect. Hence, it was the most promising 
aspirant for further investigations. We focused on Dscam and examined its expression on 
mRNA and protein level in rat microglia cells. Additionally, a functional knock-down 
experiment was performed. 
Even though Dscam expression was shown several times, we could not clearly confirm its 
expression in rat microglia cells, since the presence of false positive cells, possible due to 
Dscam positive contaminants could not be completely excluded. 
Future studies should be done to further address the possible role of Dscam in mammalian 
immune responses. Helpful in this regard would be more and novel literature about microglia 
diversity as well as the development of an appropriate antibody. 
 
 
 
 
  
Zusammenfassung 
 
Mikrogliazellen sind spezialisierte Makrophagen, die im Gehirn und Rückenmark 
vorkommen. Basierend auf der Expression eines Antikörper (5D4)- reaktiven Keratansufat- 
Proteoglykans auf der Oberfläche der Zellen konnten zwei funktionell unterschiedliche 
Populationen charakterisiert werden. Zellen mit geringerer Expression (5D4low) sind 
immunologisch aktiver, als jene mit hoher Expression (5D4high). Ein Vergleich von 5D4high- 
und 5D4low- Microarray Daten führte zur Entdeckung vieler Gene, welche im Bezug auf 
Entwicklung und Funktion von Mikrogliazellen von großem Interesse sein könnten. Fünf 
Gene, welche eine erhöhte Expressionsrate in 5D4high Mikrogliazellen zeigten, wurden 
untersucht: Cadm1, Dlx2, Dscam, Tef und Twist-2. Die Expression aller Gene außer Cadm1 
konnte auf mRNA Ebene nachgewiesen werden. 
Für unsere Fragestellung war Dscam aufgrund seiner Funktion im Immunsystem von 
Drosophila und wegen seiner homo- und heterophiler Interaktionen sehr interessant. Deshalb 
entschieden wir uns, die Expression von Dscam in Mikrogliazellen auf mRNA- und Protein- 
Ebene genauer zu untersuchen. Zusätzlich führten wir ein funktionelles Knock-Down 
Experiment durch. 
Obwohl wir Dscam mehrmals nachweisen konnten, war es uns nicht möglich seine 
Expression in Ratten- Mikrogliazellen definitiv zu bestätigen, da mögliche falsch positive 
Zellen nicht mit Sicherheit ausgeschlossen werden konnten. 
Zukünftige Studien sollten die Rolle von Dscam im Säugetier- Immunsystem verifizieren. 
Weitere Erkenntnisse über Mikroglia- Diversität und die Entwicklung eines neuen, geeigneten 
Antikörpers könnten dabei zielführend sein. 
 
 
 
Introduction 
 
Approximately 20% of the total glial cell population in the central nervous system 
comprise of microglial cells (MG), which belong to the mononuclear phagocyte system and 
form the resident macrophages in the brain tissue, the spinal cord and the retina (Kreutzberg, 
1995). 
MG populate the CNS first during early development, deriving from progenitors whose 
origin is the yolk sac (Figure 1, Alliot et al., 1999) and second via the supraventricular corpus 
callosum consisting of cells originating from bone marrow-derived myeloid progenitor cells 
(Ritter et al., 2006), named as “Fountain of microglia” (Del Rio-Hortega, 1932). 
 
 
Figure 1. Cross section through a mouse brain rudiment (E10). Bright cells are F4/80 positive 
(macrophage/microglial marker), and thereby represent cells of the mononuclear phagocyte system, 
which are initially found in the mesenchyme (M). Some of them (see arrow) infiltrate the 
neuroepithelium (NE) and eventually become microglia. Bar equals 40 μm (Figure taken from Alliot et 
al., 1999). 
 
These cells actively proliferate locally and disperse throughout brain and spinal cord 
tissue (Alliot et. al, 1999). 
MG assume an important local surveillance role, they remove dead cells and other debris 
from their surroundings and they express receptors for complement, immunoglobulin and 
apoptotic-cell surface markers. In the normal brain, these resting microglia are highly 
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ramified (Raivich, 2005). Activating stimuli lead to secretion of a large number of different 
factors, with which they play a role in tissue destruction and tissue repair/protection. Hence, 
they were termed “sensors of CNS pathology”. Profound knowledge of intercellular signalling 
pathways of proliferation/activation in microglia could be a basis for targeted intervention on 
glial reactions in the CNS (Kreutzberg, 1996). 
 
Recent studies showed that there are two different microglia populations in the rat, based 
on the expression of an antibody-reactive keratan sulfate proteoglycan (KSPG) on their cell 
surface. This antibody, named “5D4”, reacts with 50 % of all ramified MG. These 5D4high 
MG are nicely intermingled with 5D4low cells throughout the brain tissue (Figure 2, Jones and 
Tuszynski, 2002). 
 
 
Figure 2. KSPG expression by MG in the intact spinal cord. The 5D4 reactive KSPG is expressed throughout 
the intact spinal cord on a subpopulation of MG but not on oligodendrocyte progenitors and astrocytes. A, 
Composite of three confocal images taken from the dorsal white matter. 5D4 reactive KSPG, green; 
MG/macrophage marker IBA1, red. Arrows indicate examples of ramified MG expressing 5D4-KSPG. Scale 
bar, 135 µm. B–D, High magnification of 5D4 reactive KSPG and IBA1 MG. 5D4 reactive KSPG 
immunoreactivity encompasses the soma and cell processes. Scale bar, 5 µm (Figure and legend taken from 
Jones and Tuszynski, 2002) 
 
There are two facts, supporting the assumption that these two populations vary in their 
functionality: 
First, two different microglia populations had also been discovered in the adult murine 
CNS, based on the expression of the innate microglial immune receptor TREM-2 (triggering 
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receptor expressed on myeloid cells-2). Both populations, TREM-2 positive and negative, 
exist side by side and differ in their functions, regarding phagocytosis or mediation of 
proinflammatory responses (Schmid et al., 2002; Takahashi et al., 2005). 
Second, this hypothesis is also supported by current knowledge of 5D4 reactive KSPG:: 
Keratan sufate proteoglycan expression on the cell surface remains stable in Wallerian 
degeneration of axotomized fiber tracts (Jander and Stoll, 1996); KSPG expression is 
increased under ischaemic conditions (Zhang et al., 2005) as well as subsequent to spinal cord 
injury (Jones and Tuszynski, 2002); and it disappears from the surface of 5D4high microglia 
cells due to experimental autoimmune encephalomyelitis (EAE), an inflammatory 
demyelinating disease of the CNS (Jander et al., 2000). 
Microarray studies on 5D4high and 5D4low microglia cells showed that these populations 
clearly differ in their expression profile and in their response to pathological conditions: 
5D4low MG seem to be immunological more active than their 5D4high counterparts, 
because they express more genes belonging to the following categories: innate defense 
molecules, receptors, factors involved in LPS response, “cytokines, chemokines and other 
attractants”, “proteins needed for vesicle traffic, exocytosis and phagocytosis”, intracellular 
signalling molecules, proteins of the complement cascade and proteins involved in 
coagulation (Leitner and Bradl, unpublished observation). 
 
Indicating a higher expression rate in 5D4high MG than in their 5D4low counterpart (Table 
1), these following 5 molecules were especially interesting for us: Cadm1, Dlx2, Dscam, Tef, 
Twist-2; 
 
Full Name Symbol Target Id p-Value log2Fold Change 
Rattus norvegicus cell adhesion molecule 1 Cadm1 NM_001012201 0,00046 1,032 
Rattus norvegicus distal-less homeobox 2 Dlx2 XM_230986 0,04063 1,109 
Rattus norvegicus Down syndrome cell adhesion molecule Dscam NM_133587 0,00208 1,093 
Rattus norvegicus thyrotrophic embryonic factor Tef NM_019194 0,02887 1,034 
Rattus norvegicus twist homolog 2 (Drosophila)  Twist2 NM_021691 0,00802 1,512 
Table 1. Microarray data of target molecules; p-values and log2fold expression in 5D4high relative to 
5D4low microglia; 
 
All these molecules might play an important role in microglia development and function: 
 
- Cell adhesion molecule 1 (Cadm1, Necl-2) is an adhesion molecule, primarily 
expressed on cytotoxic T cells, involved in tumor suppression, synapse formation, 
and spermatogenesis. It defines a specialized subset of DCs in both mouse and 
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human. Cadm1 a ligand for class I MHC-restricted T-cell associated molecule 
(Crtam) and it was proposed that this molecular pair could regulate a large panel of 
cell/cell interactions both within and outside of the immune system (Galibert et al., 
2005).  
- Dlx2: A homeobox transcription factor family, called Distall-less (Dlx), primarily 
implicated in murine development, had been analyzed in natural killer cells (NK). 
Therefore a gene expression profile approach was performed, using a mouse 
model in which NK cells are arrested at an immature stage of development. It 
could be demonstrated, that Dlx1, Dlx2, and Dlx3 are transiently expressed in 
immature Mac-1lo NK cells. These genes are expressed in a temporally regulated 
pattern with overlapping waves of expression, and they display functional 
redundancy. It was observed that persistent expression of Dlx genes leads to 
functionally immature NK cells arrested at the Mac-1lo stage and that T and B cells 
fail to develop in the context of continuing Dlx1 expression. Thus, these studies 
indicate that Dlx transcription factors play a functional role in lymphocyte 
development (Sunwoo et al., 2008). 
- Down syndrome cell adhesion molecule (Dscam) was first described in neuronal 
development. Recent studies present Dscam in a new context: D. melanogaster 
immune tissues can express more than 18,000 different extracellular domains of 
Dscam and soluble forms of Dscam have also been identified in cell supernatants 
and in the haemolymph. Dscam potentially acts as both a phagocytic receptor and 
an opsonin. This suggestion is supported by the identification of Dscam in the 
phagosome proteome of Drosophila. The crystal structures of two Dscam isoforms 
reveal each one with two distinct surface epitopes, one on either side of the 
receptor. This configuration allows a given Dscam isoform to form a homodimer 
(epitope I) and retain the ability to recognize, opsonize and crosslink pathogens 
(epitope II) (Stuart and Ezekowitz, 2008). A horseshoe-shaped configuration was 
observed by crystallographic analyses of D1-D41.34 (splice variant 1 of exon 4 and 
splice variant 34 of exon 6) proteins of Dscam (Figure 3, Meijers et al., 2007). 
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Figure 3. Horseshoe- shaped structure of Dscam D1-D41.34: Ribbon diagram (A) and surface 
representation of epitope I (left) and II (right) on either side of molecule (B). Colour code: 
conserved residues are coloured cyan, variable residues are green and hypervariable residues are 
red (Figure taken from Meijers et al., 2007). 
 
A limited set of homophilic binding interfaces implicate a high evolutionary 
selection pressure, and thereby a strong sequence conservation in epitope I. 
Whereas epitope II was shown to be a faster evolving sequence, consistent with 
immune receptor adaptations to dynamic alterations in host– pathogen interactions. 
Therefore it was hypothesized that this structural separation of homophilic and 
heterophilic binding (that is potentially self and non-self recognition) in Dscam 
may have enabled the parsimonious use of the same gene in creating a large 
receptor diversity in both the nervous system and immune system (Meijers et al., 
2007). 
- Tyrotroph embryonic factor (Tef): Chimeric transcription factors are generated in 
leukemia, resulting in gain or loss of function of a gene. HLF (E2A- hepatic 
leukemia factor) contributes to leukemogenesis through its potential to inhibit 
apoptosis. Physiologic counterparts are of particular interest: Tef was found to 
share high levels of sequence identity with HLF and recognizes the same DNA 
sequence. Tef protected IL-3 dependent cells from apoptosis by IL-3 deprivation, 
due to almost complete down-regulation of the common βc chain of cytokine 
receptors. These findings suggested that Tef is one of the apoptotic regulators in 
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hematopoetic progenitors and to control hematopoetic cell proliferation by 
regulating the expression of cytokine receptor βc chain (Inukai et al., 2005). 
- Twist-2: Basic helix loop helix transcription factor Twist-2 is described to be a key 
negative regulator of myeloid linage development. Twist-2 deficient mice showed 
a marked increase of mature myeloid populations. Interaction with the 
transcription factors Runx1 and C/EBPα results in their inactivation followed by 
inhibition of proliferation and differentiation of granulocyte macrophage 
progenitors. The production of proinflammatory cytokines (IL-12, IFN-γ) is 
inhibited, while regular cytokines (IL-10) are promoted. In summary, Twist-2 was 
characterized as a critical factor in regulation of myeloid lineages, as well as in 
function and inflammatory responses of mature myeloid cells (Sharabi et al., 
2008). 
 
Are all of these five molecules really expressed in MG? In an attempt to confirm the 
microarray data described above, several MG populations were analyzed by PCR to address 
this point. 
Then, we concentrated on Dscam, since its action as phagocytic receptor and as an 
opsonin in Drosophila was particularly interesting to us with respect to macrophage/microglia 
cell function. 
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1. Material and Methods 
 
1.1. Cell biology 
 
1.1.1. Media 
 
Microglia culture medium 
 
RPMI 1640 without L-Glutamine (Lonza Group, Ltd. Basel, Switzerland) was 
supplemented by 10 % (v/v) Fetal Bovine Serum (FBS; Lonza Biowhittaker®), 1 % (v/v) 
Penicillin/Streptavidin (10.000 U/ml, Lonza Biowhittaker®) and 1 % (v/v) L- Glutamin 
(200 mM in 0,85 % NaCl) – (Lonza Biowhittaker®). Glutamine is an unstable essential amino 
acid and is therefore added prior to use. Microglia culture medium was prepared fresh and 
used for four to five days at most. 
RPMI 1640, Roswell Park Memorial Institute medium, is a typical medium used in cell 
cultures and contains glucose, salts, amino acids and vitamins. It is intended to be used in a 
5 % carbon dioxide atmosphere because of its contained phosphate-buffer system. 
Microglia medium with reduced FBS concentration, 5 % (v/v), was used for knockdown 
experiments with Endo-Porter and Morpholios. 
FBS is derived from blood drawn from bovine fretuses. It’s the most widely used serum 
and is used for growing eukaryotic cells. Bovine serum albumin, BSA, the globular protein, is 
a major component of FBS. 
 
DMEM (Lonza Biowhittaker®) 
 
Dulbecco´s Modified Eagle Medium is a standardized cell culture medium for animal 
cells. It contains certain amounts of glucose, anorganic salts, amino acids, vitamins and other 
substances. 
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Freezing medium 
 
RPMI 1640 without L-Glutamine (Lonza Group, Ltd. Basel, Switzerland) was 
supplemented with 45 % (v/v) Fetal Bovine Serum (FBS; Lonza Biowhittaker®) and 10 % 
(v/v) DMSO (≥99 %, Sigma-Aldrich®). 
DMSO, Dimethylsulfoxyde, is an organic solvent which is used as cryoprotective 
additive. It prevents the formation of ice crystals which would damage the cells. 
 
1.1.2. Model organisms 
 
Procedures involving animals were performed in consideration of the institutional 
guidelines. The animals had free access to food and water. 
Newborn Lewis rats or newborn C57BL/6N mice were used for microglia cultures. For 
microglia isolation and purification experiments, 2 to 7 month old Lewis rats were used. 
 
1.1.3. Preparation of primary mixed glial cell cultures 
 
Poly L- lysine (Sigma-Aldrich®, Cat. Nr. P2636) coated cell culture flasks (Greiner Bio 
One) were washed with sterile PBS and used for culturing of the cells at 37 °C and 5 % CO2. 
Newborn Lewis rats or new born mice were quickly decapitated and the head was kept in 
a petri dish containing 70 % ethanol. Then the brain was excised, placed in a petri dish 
containing DMEM and the meninges were removed using two forceps. The brain was then 
transferred into a petri dish containing microglia medium, homogenized by pipetting and 
transfered into a washed Poly L- lysine coated cell culture bottle. The formation of a solid 
mixed glial cell monolayer for microglia production was optimal with one brain in 10 to 
15 ml microglia medium per cell culture flask. 
After 24 hours the supernatant was aspirated and 10 ml fresh microglia medium was 
added. After six to seven days of incubation at 37 °C, a cell monolayer developed and 
microglia cells could be harvested by shaking the flask (rotary shaker, Infors® HT – CH-4103, 
at 160 to 180 RPM) for one to four hours. Usually a total of three shake offs were performed 
with a period of three to four days between them so that microglia cells could proliferate 
again. 
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1.1.4. BD PuraMatrix™ peptide hydrogel 
 
The PuraMatrix™ hydrogel peptide (Becton Dickinson) is new synthetic material which 
forms a defined three dimensional microenvironment for a variety of cell-based assays. It 
consists of standard amino acids (1 % w/v) and 99 % water. The manufactorer´s instruction 
for “3D Cell Encapsulation in Cell Culture Plates” was used. 
First, the BD PuraMatrix stock solution (1 %, w/v) was sonicated in a bath sonicator for 
30 min to decrease viscosity. Then one part each, sterile 20 % fructose solution and BD 
PuraMatrix stock solution, and two parts of 5·105 to 10·105 microglia cells in sterile 10 % 
fructose solution were mixed. Fructose was diluted in sterile water, as salts would start the 
gelation of the gel immediately. The microglia cells were either taken from shake off, frozen 
or from cold- shock detached plates. Culture media was removed, and the cells were washed 
and resuspended in sterile 10 % fructose solution. 
The mixture was carefully placed in the centre of a well (24-well plate), without 
introducing any air bubbles. Gelation of the BD PuraMatrix was induced by gently running 
culture media (RT) down the side of the well on top of the hydrogel. Then the media was 
changed two times over the next 30 to 60 minutes. 250 µl of the mixture was used per well 
and 300 µl microglia medium were added. 
The setup for Ultramicroscopy (see 1.1.8) was done using 6- well plates, coverslips and 
small plastic rings (see Figure 4) to obtain cake-shaped BD PuraMatrix pieces. About 1 ml of 
the mixture and 6 to 8 ml of microglia medium were needed. The plastic ring was carefully 
removed immediately before investigation, as the gel is easily damageable. 
 
 
 
 
Figure 4. BD PuraMatrix plastic ring Ultramicroscopy setup. 
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1.1.5. Isolation of microglia from adult lewis rat spinal cords 
 
The animals were killed by CO2 suffocation. Cardiac arrest was reached within few 
minutes. The vena cava inferior and the vena portae in the liver were transected and the blood 
was flushed out of the vasculature by transcardial perfusion with PBS. The spinal cord was 
taken out, transferred into ice-cold RPMI 1640, and the meninges and processes of the 
peripheral nerves were removed. Then, the spinal cords were mechanically dissociated 
through a stainless-steel sieve (screens for CD-1, size 100 mesh, Sigma-Aldrich®). This 
procedure results in a dissociated single cell suspension. It was collected in 25 ml of RPMI 
medium (density, ρ = 1,012 g/ml) in a 50 ml tube (maximal cells from three spinal cords per 
tube). To this cells suspension, 10,8 ml Percoll™ (ρ = 1,130 g/ml at RT) (Amersham 
Biosciences) were added. The final cell suspension then had a density of ρ = 1,048 g/ml. 
For the density gradient centrifugation 400 µl of distilled water and 10 ml Percoll™ were 
mixed to ρ = 1,125 g/ml and carefully added to the cell suspension. Since this Percoll™ 
solution had a higher density than the cell suspension, the newly added Percoll/H2O solution 
formed a cushion underneath the cell suspension. 
This gradient was centrifuged at 3.000·g for 40 min at RT (no brake to avoid mixing of 
the different phases). The myelin debris on top of the solution was aspirated and the microglia 
cells and macrophages were collected from the clear phase of the upper layer (see Figure 5). 
 
 
 
Figure 5. Desity gradient centrifugation, phase profile before and after 
centrifugation (figure kindly provided by Rui Martins). 
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The cells were harvested in approximately 25 ml medium into a new 50 ml centrifuge tube 
and were pelleted by centrifugation at 1.400·g for 30 min at RT. Then, all supernatant was 
removed except of 200 µl. The cell pellet was resuspended in the remaining supernatant and 
centrifuged again at 1.400·g for 10 min at RT. Finally, the supernatant was removed and the 
pellet was resuspended in 200 µl medium. 
 
 
1.1.6. Lymphocyte isolation 
 
The blood was collected in a tube containing anticoagulant and diluted by adding an equal 
volume of 0,9 % NaCl. Then 6 ml of the diluted blood were layered on top of 3 ml of 
LymphoprepTM. This was followed by centrifugation at 800·g for 20 minutes. Mononuclear 
cells were taken from the distinct band at the sample/media interface (see Figure 5). 
 
 
 
Figure 6. Lymphoprep™, AXIS-SHIELD (Figure adapted from 
http://search.cosmobio.co.jp/). 
 
1.1.7. Phase-contrast microscopy and imaging 
 
An inverted microscope (DM IL, Leica® Microsystems) attached to an SLR CCD Camera 
(E-300, Olympus) was used for microscopy of the cells in the petri dishes and flasks through 
10X, 20X, and 40X objective lenses and phase-contrast optics.  
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1.1.8. Ultramicroscopy 
 
This method was developed to visualize individual cells and cellular structures in opaque 
objects (Dodt et al., 2007). The basic principle of this method (Figure 7) is the immersion of 
the specimen in a medium with the same refractive index as protein. This allows 3D imaging 
with micrometer resolution of macroscopic samples. 
 
 
Figure 7. Principle of ultramicroscopy. The sample is illuminated by a blue 
laser forming a thin sheet of light. Fluorescent light is thus emitted only from a 
thin optical section and collected by the objective lens. (Figure taken from Dodt 
et al., 2007). 
 
The cells in the PuraMatrix peptide hydrogel were stained with tomato-lectin- FITC 
conjugate (see 1.3.1) which was added to the medium. After incubation for 30 minutes the gel 
was rinsed and washed with fresh medium very carefully. Lectins are very specific sugar-
binding proteins and are often used by viruses to attach themselves to their host cells. 
 
1.2. Molecular Biology 
 
1.2.1. Isolation of total RNA, DNAse digestion and RNA Cleanup 
 
The Quiagen RNeasy® Mini Kit was used to isolate total RNA according to the 
manufacturer’s instructions. This was followed by elimination of genomic DNA 
contamination by DNAase digestion. 7 µl 10X DNase I Buffer (Fermentas), 7 µl DNase I 
(1 u/μl, Fermentas) and 2 µl Ribolock® RNase inhibitor (40 u/µl, Fermentas) were added to 
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54 µl of total RNA sample and incubated at 37ºC for 30 minutes. Then 7 μl EDTA were 
added and the sample was incubated at 65 ºC for 10 min to chelate and stop the reaction. 
Total RNA was then further purified using the Quiagen RNeasy® Mini Kit according to 
the RNA Cleanup- protocol. 
 
1.2.2. Reverse Transcription 
 
Starting from total RNA after RNA Cleanup, cDNA was obtained by reverse 
transcription. First, 2 μl of random primers (T7-N7) were added to each sample and incubated 
at 70 °C for 5 min and another 5 min on ice. Then 20 µl master mix was added per sample, 
consisting of the following components: 
 
10 μl M-MLV 5X RT Buffer (Promega Corporation) 
2,5 μl PCR grade dNTPs (Roche Applied Science) 
2,5 μl Ribolock® RNase inhibitor (40 u/μl, Fermentas) 
5,0 μl ddH2O 
 
The sample was incubated at 40 ºC for 2 min, 2 μl M-MLV Reverse Transcriptase 
(200 u/μl, Promega Corporation) were added, left at RT for 10 minutes and then placed in a 
thermoblock at 40 ºC for 50 minutes. Finally, the sample was incubated at 70 °C for 15 min. 
cDNA samples were stored at -20 °C. 
 
1.2.3. Synthesis of DIG- labeled cRNA 
 
DIG RNA Labeling Kit (SP6/SP7) (Roche, Cat.No. 11175025910) was used to produce 
DIG-labeled cRNA from PCR-products for Northern blot. Labeling quality was analyzed by 
dot blotting. 
 
The probe must be complementary to the target mRNA. The PCR-product, provided by 
the T7-tagged forward primer, enables the T7-polymerase to produce mRNA-complementary 
copy-RNA from mRNA-homolog cDNA (Figure 8). See 1.2.5 for primer sequences. 
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 Figure 8. Northern probe preparation 
 
The T7-GAPDH_large- fragment (758 bp) was obtained by PCR from microglia cDNA 
(Figure 9). 
 
 
Figure 9. GAPDH_large- probe; negative controls without 
template; GAPDH_large and T7GAPDH_large PCR products 
(738 and 758 bp respectively); 
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The first trial to synthesize the probe for Dscam was not effective to obtain the T7 
conjugated Dscam- fragment. So I produced high amounts of the T7- exclusive fragment 
(Figure 10). 
 
 
Figure 10. Dscam_large- PCR product (821 bp). 
 
Concentrating in a small volume and using this PCR fragment as template for PCR with 
the T7- conjugated primer was effective (Figure 11). 
 
 
Figure 11. T7-conjugated Dscam_large PCR fragment (841 bp), 
compared to Dscam_large PCR product (821 bp); 
 
The T7 conjugated PCR products were purified from gel and used for probe preparation. 
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1.2.4. Dot blot 
 
One µl of 1:5, 1:25 and 1:125 diluted pobe was dropped on a nylon membrane and 
crosslinked by Stratalinker® UV Crosslinker (Model 1800, #400072). Then it was blocked in 
Roche Blocking Reagent (Cat.No. 11096176001), supplemented with 10% Fetal Bovine 
Serum (FBS; Lonza Biowhittaker) over night. 
Detection was done using NBT/BCIP (Roche Applied Science) according to the 
manufacturer’s instructions.  
 
1.2.5. PCR and Gelelectrophoresis 
 
For the polymerase chain reaction (PCR), the master mix was prepared fresh from 5 μl 
PCR Reaction Buffer(10X, 20 mM MgCl2), 1 μl dNTP Mix, 0,4 μl FastStart Taq DNA- 
Polymerase (5 U/µl) and 1 µl forward and reverse primer for 1 µl template DNA. PCR 
Reaction buffer, dNTP Mix and Fast Start Taq provided by Roche Applied Bioscience; 
Biometra® TPersonal thermocycler was used. 
Primers were design using the Primer3Plus service (Rozen and Skaletsky, 2000) on the 
WWW (http://www.genome.wi.mit.edu/cgi-bin/primer/primer3-_www.cgi) provided by 
Whitehead Institute/MIT Center for Genome Research and ordered from Eurofins MWG 
GmbH. 
 
Table 2. Primer-sequences and melting temperatures. 
Name Sequence (5´ ? 3´) TM 
[°C] 
Accession 
number 
Cadm1_Fwd AGATTCTCGAGCAGGTGAAGAG 60,3 NM_001012201.1
Cadm1_Rev ATGATGAGCAAACATAGCATGG 56,5 NM_001012201.1
Dlx2_Fwd TGGAGTCTTTGACAGTCTGGTG 60,3 XM_230986.4 
Dlx2_Rev GTTGGTGTAGTAGCTGCTGTCG 62,1 XM_230986.4 
Tef_Fwd TTGCAGTAGATATGCACCCAAC 58,4 NM_019194.2 
Tef_Rev CTGAGAAGGGATACTGGGTGAC 62,1 NM_019194.2 
Twist2_Fwd AGCAAGAAATCGAGCGAAGAT 55,9 NM_021691.1 
Twist2_Rev CAGCTGGTCATCTTATTGTCCA 58,4 NM_021691.1 
ratGAPDH_Fwd GGCATTGCTCTCAATGACACC 59,8 NM_017008 
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ratGAPDH_Rev TGAGGGTGCAGCGAACTTTAT 57,9 NM_017008 
ratGAPDH_large_Fwd GAGTCTACTGGCGTCTTCAC 59,4 NM_017008 
ratGAPDH2_large_Rev GTCCAGGGTTTCTTACTCCT 57,3 NM_017008 
T7ratGAPDH_large_Fwd TAATACGACTCACTATAGGG- 
GAGTCTACTGGCGTCTTCAC 
59,4 NM_017008 
Dscam_small_Fwd CGGACGCATAAGTGAAATCATA 56,5 NM_133587.1 
Dscam_small_Rev GCATCTGCAGTTCATACCATGT 58,4 NM_133587.1 
Dscam_middle_Fwd UCCAAUCACCUCAUUCACUC 55,3 NM_133587.1 
Dscam_middle_Rev TCTCCATTGTGTCTCTCTCT 55,3 NM_133587.1 
Dscam_large_Fwd CACTCCAGCCTCTACTTTGTCAAT 61,0 NM_133587.1 
Dscam_large_Rev GTTATCTTTCAGCCAGCGGTAGTC 62,7 NM_133587.1 
T7Dscam_large_Fwd TAATACGACTCACTATAGGG- 
CACTCCAGCCTCTACTTTGTCAAT 
61,0 NM_133587.1 
 
 
Gelelectrophoresis was performed in PerfectBlue™ gelelectrophoresis system (PEQLAB 
Biotechnologie GmbH) with 1 % agarose gel, using 12 µl Ethidium bromide solution (Sigma-
Aldrich®) per 300 ml of gel. 
As DNA size marker peqGOLD 1 kb DNA-ladder (PEQLAB Biotechnologie GmbH) was 
used (Figure 12). 
 
 
Figure 12. peqGOLD 100 bp DNA-Ladder (PEQLAB Biotechnology GmbH). 
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 The Wizard® SV Gel and PCR Clean-Up System was applied to concentrate PCR 
reactions and for DNA extractions from agarose gel after electrophoresis. 
 
1.2.6. Morpholino Antisense Oligo- Knock down 
 
Morpholino Oligomeres (Gene Tools, LLC) are chains of several morpholino subunits. 
Each subunit is made of a ribonucleoside, which was transformed to a morpholino, protected 
by a trityl- and activated by a phosphoramidate- link. The target sequence can be the mRNA 
5' UTR through the first 25 bases of coding sequence (blocking translation initiation in the 
cytosol), splice junctions or splice regulatory sites (modifying pre-mRNA splicing in the 
nucleus), mature miRNA or pre-miRNA (inhibiting miRNA maturation and activity) or other 
cellular RNAs (ribozyme inhibition or translational frameshifting). 
Translational knock down is done by sterically inhibition of the formation of the 
translational initiation complex (Figure 13). 
 
  
Figure 13. Ribosome assembly is blocked by morpholino (Figure from Gene 
Tools, LLC, slightly modified). 
 
 
Morpholinos do not degrade their target and act as RNAse H independent high affinity 
segment. This implicates that morpholinos action on gene expression cannot be analyzed on 
RNA level. 
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It has been shown that Morpholinos have a higher binding affinity than an equivalent 
DNA-based antisense oligo (http://www.gene-tools.com/) and are therefore capable to give 
reliable results. 
Morpholino delivery can be done by a variety of methods. We decided to choose the 
Endo-Porter delivery system. It’s a novel peptide which delivers substances by an 
endocytosis-mediated process working in presence of serum, avoiding plasma membrane 
damage the of the cell. There is no interaction between target and delivery system. The 
mechanism of delivery is based on endocytosis, mediated by the Endo-Porter, followed by 
acidification of the endosome. The ionic form of the Endo-Porter permeabilizes the endosome 
and its content is released into the cytosol (Figure 14). 
 
 
Figure 14. Endo-Porter delivery system: 1.) Endo-Porter’s hydrophobic face binds to the cell membrane; 
2.) Endocytosis is induced and the Endo-Porter is co-endocytosed along with the morpholinos in the 
muedim; 3.) Natural acidification of the endosome protonates Endo-Porter that, in its ionic form, 
permeabilizes the endosome; 4.) Morpholinos are released into the cytosol (Figure kindly provided by Rui 
Martins). 
 
For our assays, we designed Morpholino oligos targeting the Dscam mRNA 
(NM_133587.1) using the following sequence: 
5´-ACAAGGAGAGAGCCAGTATCCACAT-3´. 
Standard control sequence was: 5´-CCTCTTACCTCAGTTACAATTTATA-3´. 
 
Knock down experiments were performed in 6-well plates. Microglia cells from a second 
shake-off (highest purity) were cultured and treated with 4 µl/ml Endoporter and 5µl/ml 
Morpholino in microglia medium with reduced serum (see 1.1.1) after about 15 hours. Empty 
controls and blanks with no Morpholino were also made. Pictures were taken before and 24 
hours after treatment. We differentiated 5 morphological states (A: dead, B: amoiboid, C: 
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bipolar, D: long-processed, E: multipolar) in microglia cells and counted them as shown in as 
shown in Figure 15 and Figure 16. 
 
 
Figure 15. The five different morphological states of microglia cells (A: dead, B: amoeboid, C: bipolar, D: 
long-processed, E: multipolar). 
 
 
Figure 16. Morphology analysis of morpholino-treated cells. A, unmarked original photo, B marked cells 
(dead cells = turquoise, amoeboid cells = red, bipolar cells = blue, multipolar cells = green, long-processed 
cells = purple), C, dots for counting on black background. 
 
1.2.7. Western blot 
 
Protein from second- shake-off- microglia and rat brain protein as positive control were 
used for western blotting. 
 
1.2.7.1. Protein isolation 
 
Protein was isolated after washing the microglia cells with PBS at RT two times. 1 ml of 
Lysis buffer (one Protease Inhibitor Cocktail Tablet, Roche Applied Science, in 10 ml 
1X RIPA lysis buffer, Pierce Biotechnology, Inc.) was added to the cell pellet from shake off, 
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completely lysed by pipetting and centrifuged for 15 min at 4 °C and 1400·g. The supernatant 
containing the whole protein was then transferred into a new 1,5 ml eppendorf tube. 
Protein measurement was done with the BCA assay kit (Pierce Biotechnology, Inc.). Total 
protein was precipitated by adding 500 μl Methanol p.A. and 250 μl Chloroform p.A. (Merck, 
KGaA) to 500 μl of each sample, and mixed by vortexing briefly. Centrifugation for 5 min at 
10000·g at RT followed and the phases were carefully separated with a micropipette. 1000 μl 
Methanol p.A. were added, vortexed to mix the phases and centrifuged again at for 30 min at 
10000·g at 4 º C. Finally, the supernatant was removed, the tube was centrifuged one more 
time for 10 min at 10000·g at 4 ºC and the pellet was allowed to air-dry at RT after removal of 
the remaining liquid. 
 
The pellet was then dissolved in 1X NuPAGE® Lithium Dodecyl Sulfate sample buffer 
(LDS buffer; Invitrogen™), 1X NuPAGE® Reducing Agent (Invitrogen™) to a final protein 
concentration of 1 to 1,5 μg/μl. The sample was then incubated at 70 ºC for 10 min and spun 
down for 2 min before finally loading. 
 
1.2.7.2. Protein Electrophoresis 
 
SDS- Page (sodium dodecylsulfate polyacrylamide gel electrophoresis) was performed to 
separate the proteins. A 5 % stacking and a 10 % separating gel were used (composition v/v, 
Table 3): 
 
 5% stacking gel 10% separating gel 
4X Separating/Stacking Buffer 
(1,5 M Bis-Tris; pH 6,4) 
25% 25% 
30% Acrylamide/Bis (Bio-Rad® Laboratories) 33% 17% 
10% SDS (Sigma-Aldrich®) 1% 1% 
Milli-Q® Water (Millipore™) 40% 56% 
TEMED (Electran, BDH) 0,1% 0,1% 
10% ammonium persulfate (APS; Amersham® 
Biosciences, GmbH) 
1% 1% 
Table 3. Stacking- and separating- gel recipe for SDS-Page. 
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For both gels ammonium persulfate was immediately added before casting, as it is the 
radical initiator for the gelation of the gel. The NOVEX® Gel Cassette (Invitrogen™) 
(precooled to 4 °C) was used for gel casting. 
First, the separating gel was prepared and poured into the chamber and 0,1 % SDS was 
layered on top. After about 4 hours of polymerization, the 0,1 % SDS was discarded and the 
gel was washed with 1X stacking buffer (0,5 M Bis-Tris; pH 6,4). Any remaining liquid was 
aspirated by a vaccum pump. 
Secondly, the stacking gel was mixed and cast on top of the separating gel. The comb was 
carefully put into the liquid gel, avoiding any bubbles, and the stacking gel was allowed to 
polymerize for 30 min. Then the comp was removed carefully and the slots were rinsed with 
stacking buffer to remove barely fixed gel remains. 
The gel assembly was then placed into the electrophoresis unit (Bio-Rad® Laboratories), 
1X MOPS buffer was prepared and NuPAGE® Antioxidant (Invitrogen™) was added to a 
final concentration of 0,25 % (v/v). 1X MOPS running buffer was poured into the inner 
chamber and the remainder was put into the outer chamber. Samples were loaded next to 
MagicMark™ Western Protein Standard (Invitrogen™) and the gel was run at a constant 
voltage of 200 V and about 130 mA for 45 min. 
 
1.2.7.3. Immunoblot 
 
The cassette was disassembled, the stacking gel was discarded and the separating gel was 
equilibrated in transfer buffer (Tris 479 mM; Glycine 386 mM; 0,5% SDS; 10% Methanol; 
Milli-Q® Water) for 15 min. A commensurate Immobilon-P Polyvinylidene fluoride 
Membrane (PVDF; Millipore™) membrane was equilibrated by dipping in methanol p.A. for 
15 sec and Milli-Q® Water (Millipore™) water for 2 min and then also placed in transfer 
buffer for 10 min. The immunoblot was set up as shown in Figure 17 and run for about 
60 min at 20 V. 
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Figure 17. Immunoblot setup (Figure kindly provided by Rui Martins). 
 
When the transfer was finished, the membrane was blocked in blocking buffer (1,5 % w/v 
Non-Fat Dry Milk powder in PBS; 0,1 % TWEEN-20) for 1 hour. The membrane was cut in 
two pieces and each incubated with one primary antibody, goat anti-human Dscam and mouse 
anti rat β-actin (see 1.3.1). They were diluted 1:500 in blocking buffer and incubated at 4 °C 
over night on a shaker. 
 
The following day, the membrane was washed three times for 15 min with blocking buffer 
and then incubated with a 1:2000 dilution of the secondary antibody, Alkaline Phosphatase- 
conjugated donkey anti-goat IgG/Alkaline Phosphatase- conjugated goat anti-mouse IgG (see 
1.3.10) in blocking buffer for one hour at RT. The three washings in bocking buffer were 
repeated with additional 3 washings in assay buffer (25 mM Diethanolamine - Fluka® 
Analytical; 1 mM MgCl2; Milli-Q® Water; pH 10,0), 5 minutes each. 
The detection was done with CDP-Star® Reagent (New England Biolabs, Inc.) as 
substrate. Assay buffer was mixed with 10 µl of the substrate and incubated for 2 min with the 
membrane, placed between two plastic foils. The results were captured using a Fluor-S™ 
Imager (λ = 290-365 nm; Bio-Rad Laboratories). 
 
1.2.8. Northern blot 
 
RNA was isolated (see 1.2.1) from CD-45low FACS-sorted microglia and from spinal cord 
as positive control. 
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1.2.8.1.
1.2.8.2.
 RNA Electrophoresis 
 
RNA tends to bind other RNAs and can easily form secondary structures. This would 
modify the running speed in electrophoresis. So, a denaturizing formaldehyde gel is used to 
prevent this process. 
For preparation of 10x MOPS buffer 0,2 M MOPS (4-Morpholinepropanesulfonic acid, 
Sigma-Aldrich®) 0,05M sodium acetate and 0,01 M EDTA were mixed and adjusted to 
pH 7,0 with 1 M sodium hydroxide. 
Agarose (1% w/v) was mixed with water and nuked to the boil. After cooling to about 
60 °C, 10x MOPS buffer (to a final concentration of 1x) and 37% formaldehyde (Sigma-
Aldrich®, to a final concentration of 7%) were added and the gel was cast. The tray, comb 
and tank were cleaned with soap, washed with RNAse-free water and dried before use. 
The RNA sample (minimum of 1 µg total RNA, measurement by NanoDrop™ analyzer) 
was mixed with 10X MOPS (to a final concentration of 1x), 37% formaldehyde (to a final 
concentration of 6,5% w/v) and formamide (to a final concentration of 50% v/v), incubated at 
60°C for 5 min, mixed with loading buffer and run on the gel for about 4 hours at 60 V. 1X 
MOPS buffer was used as running buffer. 
 
 Blotting 
 
The gel was washed with water two times and placed in 10x SSC buffer for 45 min with 
shaking. The nylon membrane was soaked in water and 20x SSC (3M sodium chloride, 3 mM 
sodium citrate, brought to ph 7.0 with HCl) 
Then the blotting setup was done as shown on in Figure 18 over night. 
 
 
Figure 18. Northern blot setup (Figure taken from http://www.biochem.arizona.edu/). 
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After this the membrane was crosslinked by a Stratalinker® UV Crosslinker (Model 1800, 
#400072). Prehybridization at 55°C for 4 hours and hybridization at 55°C over night 
followed. Buffers were prepared as listed in Table 4. The hybridization probe (minimum of 
100 ng, measured by NanoDrop™ analyzer) was prepared as described in 1.2.3. 
 
 
Substances  Prehybridization 
buffer 
Hybridization 
buffer 
Formamide 50% 50% 
100x Denhardts solution 
(each 0,2% w/v BSA, Polyvinilpyrolidone and Ficoll 
in water 
5x 2,5x 
20% SDS 1% 1% 
10 mg/ml salmon sperm DNA 200 µg/ml 200 µg/ml 
20x SSPE 
(3 M sodium chloride, 200 mM sodium dihydrogen 
phosphate, 200 mM EDTA in water, adjusted to pH 
7.4) 
5x 5x 
Water   
Table 4. Hybridization buffer recipes for Northern blot. 
 
After hybridzation, three washing steps with 1x SSPE, 0,1% SDS at 55°C for 20 min and 
one with 0,1x SSPE, 0,1% SDS at RT for 50 min were performed. Last, the substrate was 
mixed and incubated for 20 min at RT. 
Detection was done using NBT/BCIP (Roche Applied Science) according to the 
manufacturer’s instructions. 
 
1.3. Immunochemistry 
 
1.3.1. Antibodies 
 
Antibodies were used for FACS, Western blot, Ultramicroscopy and tissues. 
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For some approaches, it was necessary to permeabilize the cells. This was performed with 
FIX&PERM® kit (Invitrogen™) according to manufacturer’s instructions. All antibodies 
used were kept at 4º C and protected from light. 
 
Table 5: Antibodies 
Name Recognizes Company Use 
Texas Red labeled 
Lycopersicon 
Esculentum (Tomato) 
Lectin 
lectin sugar moieties Vector Laboratories Ultramicroscopy 
Monoclonal human 5D4 Human Keratansulphate proteoglycan 
Seikagaku 
Corporation FACS 
Polyclonal goat anti-
human DSCAM 
Human DSCAM 
extracellular domain R&D systems 
FACS 
IHC 
WB 
Cy™5-conjugated* 
AffiniPure Donkey 
Anti-Goat IgG (H+L) 
Goat IgG Jackson ImmunoResearch 
FACS 
IHC 
Biotin-SP-conjugated 
AffiniPure Bovine Anti-
Goat 
Goat IgG Jackson ImmunoResearch IHC 
Cy™5-conjugated 
Streptavidin Biotin 
Jackson 
ImmunoResearch 
FACS 
IHC 
FITC- conjugated 
monoclonal mouse 
CD45 
Rat thymocyte membrane 
glycoproteins AbD Serotec FACS 
FITC- conjugated 
monoclonal anti-rat 
CD11b 
Rat CD11b AbD Serotec FACS 
PE-conjugated 
polyclonal donkey anti-
goat IgG H&L – F(ab)2 
fragment 
Goat IgG whole molecule abcam® IHC 
Biotin-SP-AffiniPure 
F(ab')2 Frag Anti-Goat 
IgG 
Goat IgG Jackson ImmunoResearch IHC 
Avidin-Peroxidase Biotin Sigma-Aldrich® IHC 
Mouse anti-rat CD11b Rat CD11b AbD Serotec IHC 
Anti mouse AP Mouse IgG Jackson ImmunoResearch IHC 
Rabbit anti-Iba1 Human, mouse, rat Iba1 WAKO IHC 
Alkaline Phosphatase- 
conjugated goat anti-
rabbit IgG 
Rabbit IgG Jackson ImmunoResearch IHC 
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Mouse monoclonal anti 
β-actin 
Hu, Ms, Rat, Cat, Chk, 
Cow, Dog, Fsh, Gpig, 
Hm, Mmst, Op, Pig, Rb, 
Shp β-actin 
abcam® WB 
Alkaline Phosphatase-
conjugated AffiniPure 
F(ab') 2 Fragment 
Donkey Anti-Goat IgG  
Goat IgG Jackson ImmunoResearch WB 
Goat polyclonal to 
Mouse IgG (Fc specific) 
(Alkaline Phosphatase) 
Mouse IgG abcam® WB 
 
 
1.3.2. Flow cytometry analysis and cell sorting 
 
Cells from isolation of the microglia from the crude CNS preparations (described in 
1.1.5), cells from shake-off or from cold shock- detached cell culture plates were used for 
FACS or flow cytometry analysis. The cell suspension was centrifuged for 1 min/ml at 1400·g 
and the pellet was resuspended in about 200 µl stain buffer. BD PharmingenTM stain buffer 
was used through staining procedures and all antibodies were offered at 4 °C or RT and for 30 
min. Each staining was followed by washing with 1-3 ml stain buffer and 10 minutes 
centrifugation at 4 °C or RT, at 1400·g. 
Fluorescence associated cell sorting (FACS) was performed using the FACSAria II cell 
sorter with the FACSDiva™ (Becton Dickinson) software at the St. Anna Kinderspital. A 
70µm wide nozzle was used for sorting, and it was performed according to Forward Scatter 
(FSC, quantifying size/viability), Side Scatter (SSC, quantifying granularity) and relative 
CD45/5D4 labeling (see 2-3-1) as parameters. The sorted cells were collected in tubes 
containing 350μL RLT lysis buffer (Quiagen RNeasy kit®) with 3,5μL β-Mercaptoethanol. 
Then the lysed cells were stored at -80ºC, or immediately processed for total RNA isolation 
(see 1.2.1). 
Flow cytometry analysis was performed with different antibodies (see 1.3.1). For some 
approaches the cells have been treated with FIX&PERM® kit (Invitrogen™) to stain 
intracellular proteins. 
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1.3.3. Histological/Cytoblock Staining 
 
Histological analysis was performed as previously described (Aboul-Enein et al., 2004): 
The animals were perfused with 4% paraformaldehyde (PFA) in phosphate buffered saline 
(PBS), brains and spinal cords were dissected, fixed in 4 % PFA/PBS for 24 hours and 
paraffin embedded. 2-4 µm thick adjacent serial sections were cut on a microtome.  
Prefixed microglia (PFA) cells from shake-off were embedded in 1 % low melting agarose 
(now referred as cytoblock), cut on a microtome and stained equally. 
 
Antigen retrieval of the Tissue/Cytoblock sections was done by rehydrating, heating in 
citrate buffer, rinsing in 0,1 M PBS and then incubation in PBS containing 10% fetal calf 
serum (PBS/FCS) for 20 minutes. After this another washing step with PBS follwed. 
Pretreatment with 0,2 % hydrogen peroxide (blocking endogenous peroxidase) was followed 
by addition of the primary antibodies goat anti-human Dscam (1:250) and rabbit anti-rat Iba1 
(1:3000), and incubated over night at 4 °C. Anti-rat ionized calcium-binding adapter molecule 
1 (Iba1) is specific for macrophages/microglia (Jones and Tuszynski, 2002). 
 
The sections were then washed in PBS and incubated with the secondary antibodies biotin 
conjugated bovine anti-goat (1:200) and alkaline phosphatase- conjugated goat anti-rabbit 
(1:200) in PBS/FBS at room temperature for 1 hour. AP-conjugated antibody was followed by 
a peroxidase-conjugated avidin (1:200) for another hour. Detection was done with 3,3’-
diaminobenzidine-tetra-hydrochloride (DAB, Sigma-Aldrich®) containing 0,01 % hydrogen 
peroxide for peroxidase and/or Fast red (Sigma-Aldrich®) for alkaline phosphatase. Brain 
sections were counterstained with Mayer’s Hämatoxylin. See 1.3.1 for antibody details. The 
complete stained sections were dehydrated and coverslipped. 
 
1.3.4. Immunostaining of mixed glia cell culture plates 
 
The cells were stained with DAB (DAB, Sigma-Aldrich®)/Fast Red or Cy3/FITC in 
culture plates with and without permeabilization. 350 µl of DAKO buffer (light microscopy), 
stain buffer (fluorescence microscopy) or microglia medium (before fixation) was used for 
staining procedures. Fixation was done by the FIX&PERM® kit (Invitrogen™) or by 
methanol/hydrogen peroxide after primary antibodies. 
Light microscopical staining were performed with goat anti-human Dscam (1:30)/biotin 
anti-goat (1:100)/avidin- peroxidase (1:100) and mouse anti-rat CD11b (1:100)/anti-mouse- 
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alkaline phoshatase (1:100). For fluorescence staining Cy3 anti-goat (1:100) and CD11b-
FITC (1:100) was used. For antibody details see 1.3.1. 
All antibodies were incubated while shaking for 1 hour at RT in the dark. Detection was 
done with 3,3’-diaminobenzidine-tetra-hydrochloride (DAB, Sigma-Aldrich®) containing 
0,01 % hydrogen peroxide for peroxidase and/or Fast red (Sigma-Aldrich®) for alkaline 
phosphatase. Finally, the walls of the plates were cut off with a hot scalpel, grinded by a razor 
and then mounted on big coverslips with geltol/gelate. 
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2. Results 
 
 
At the beginnings of my work 5D4high and 5D4low microglia had been characterized and 
analyzed by microarrays (Ephraem Leitner, diploma thesis, 2008). It was found that the 
expression levels of many molecules differ dramatically between the two populations. The 
following 5 molecules were especially interesting for us: Cadm1, Dlx2, Dscam, Tef, Twist-2; 
These molecules had higher expression levels in 5D4high MG than in their 5D4low 
counterparts (Table 6). 
 
Full Name Symbol Target Id p-Value log2Fold Change 
Rattus norvegicus cell adhesion molecule 1 Cadm1 NM_001012201 0,00046 1,032 
Rattus norvegicus distal-less homeobox 2 Dlx2 XM_230986 0,04063 1,109 
Rattus norvegicus Down syndrome cell adhesion molecule Dscam NM_133587 0,00208 1,093 
Rattus norvegicus thyrotrophic embryonic factor Tef NM_019194 0,02887 1,034 
Rattus norvegicus twist homolog 2 (Drosophila)  Twist2 NM_021691 0,00802 1,512 
Table 6. Microarray data of target molecules; p-values and log2fold expression in 5D4high relative to 
5D4low microglia; 
 
All these molecules might play an important role in microglia development and function: 
 
- Cell adhesion molecule 1 (Cadm1, Necl-2) is a ligand for class I MHC-restricted T-
cell associated molecule (Crtam) and it was proposed that this molecular pair 
could regulate a large panel of cell/cell interactions both within and outside of the 
immune system (Galibert et al., 2005). 
- Dlx2: Distal-less homeobox transcription factors (Dlx) are involved in lymphocyte 
development (Sunwoo et al., 2008). 
- Down syndrome cell adhesion molecule (Dscam) was first described in neuronal 
development. Recent studies present Dscam in a new context: D. melanogaster 
immune tissues can express more than 18,000 different extracellular domains of 
Dscam and soluble forms of Dscam have also been identified in cell supernatants 
and in the haemolymph. Dscam potentially acts as both a phagocytic receptor and 
an opsonin. This suggestion is supported by the identification of Dscam in the 
phagosome proteome of Drosophila. The crystal structures of two Dscam isoforms 
reveal each one with two distinct surface epitopes, one on either side of the 
receptor. This configuration allows a given Dscam isoform to form a homodimer 
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(epitope I) and retain the ability to recognize, opsonize and crosslink pathogens 
(epitope II) (Stuart and Ezekowitz, 2008). 
- Tyrotroph embryonic factor (Tef) was found to be one of the apoptotic regulators in 
hematopoetic progenitors and to control hematopoetic cell proliferation by 
regulating the expression of cytokine receptor βc chain (Inukai et al., 2005). 
- Twist-2 has been characterized as a critical factor in regulation of myeloid lineages, as 
well as in function and inflammatory responses of mature myeloid cells (Sharabi et 
al., 2008). 
 
Microarray data give a first hint at RNA expression, but they have to be confirmed by 
other techniques. Therefore, I first tried to confirm these findings by PCR. 
 
2.1. MG express Dlx2, Dscam, Tef and Twist-2 mRNA 
 
I isolated cDNA from a 2nd microglia shake-off, which is known to contain the purest 
microglia population, and used it for PCR with primers (see Table 2. Primer-sequences and 
melting temperatures.) specific for the five target genes and GAPDH as control, resulting in 
qualitative information about expression of Cadm1, Dlx2, Dscam, Tef and Twist2 mRNA 
transcripts. This sample was used to get information about the whole microglia population. 
Defined, sorted populations were used in further steps. 
Four out of five target genes could be confirmed by PCR: Dlx2 (two bands at 211 bp and 
~1 kb), Dscam_small (one band at 269 bp), Tef (one weak band at 238 bp) and Twist2 (one 
band at 293 bp), while Cadm1 products were missing (Figure 19). 
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 Figure 19. Gelelectrophoresis of GAPDH (310 bp), Cadm1 (105 bp), Dlx2 (211 bp), 
Dscam (269 bp), Tef (238 bp), Twist2 (293 bp) PCR products. cDNA from pure 
shake-off microglia was used. 
 
 
PCR products from Dlx2, Dscam_small, Tef and Twist2 were purified (see 1.2.1) for 
further confirmation by sequencing. The upper 1 kb product (Dlx2) could not be detected by 
sequencing with Dlx2 primers. All products had a >98% sequence identity to their targets: 
 
Primer used for 
sequencing 
Identities 
product/target 
Dlx2 Fwd 182/182 (100,0%)
Dlx2 Rev 177/177 (100,0%)
Dscam_small Fwd 238/238 (100,0%)
Dscam_small Rev 129/131 (98,5%) 
Tef Fwd 205/205 (100,0%)
Tef Rev 204/207 (98,6%) 
Twist2 Fwd 208/211 (98,6%) 
Twist2 Rev 262/263 (100,0%)
Table 7. Blast results of the found PCR- product sequences. 
 
For the rest of my studies, I concentrated on Dscam. Since Dscam is an extremely long 
protein, and since its RNA is subject to extensive splicing, we selected additional primes for 
further studies. Their positions are illustrated in Figure 20 and listed in Table 8: 
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 Figure 20. Dscam (NM_133587), including annotated Dscam PCR- product positions 
 
 
 Fwd Rev Length 
Dscam_small 4853-4873 5100-5121 268 bp
Dscam_middle 4988-5007 5486-5505 517 bp 
Dscam_large 537-560 1239-1262 726 bp 
Table 8. Dscam primer positions and PCR- product lengths. 
 
These primers were used to further confirm the presence of Dscam transcripts in microglia 
cells:  
 
 
Figure 21. Gelelectrophoresis of GAPDH (310 bp, pos. control) and Dscam_middle (517 bp) PCR 
products. Dscam transcripts were found in microglia from 2nd shake-off (1) and CD45-low cells 
from healthy adult rat spinal cords (2) and PLP transgenic adult rat spinal cords (4), whereas 
CD45-high cells from healthy adult rat spinal cords (3) and PLP transgenic adult rat spinal cords 
(5) and macrophages from peritoneum (6) and spleen (CD45-low sort) (7) appeared to be Dscam- 
negative. 
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Dscam_middle (517 bp) was detected in microglia from the 2nd shake off and in sorted 
microglia (CD45low) from healthy and PLP transgenic rat spinal cords by PCR. CD45high cells 
from spinal cord- sorting and macrophages from peritoneum or spleen (CD45high sorted) 
appeared to be Dscam negative. 
 
We were also able to obtain PCR products from the N- termius of Dscam, using the 
Dscam_large primers, which yielded a product in the expected range of 821 bp. 
 
 
Figure 22. Gelelectrophoresis of Dscam_large- PCR product 
(821 bp). The transcript was found in microglia from the 2nd 
shake off. 
 
Cumulatively, these data strongly suggested that MG, but not macrophages express 
Dscam transcripts. Do they also make Dscam protein? 
 
2.2. Microglia cells express Dscam protein 
 
To study the expression of Dscam protein, we used total protein from rat microglia from 
the 2nd shake off and from rat brain (as control) for Western blotting with Dscam and β-Actin 
antibodies (see 1.3.1). Two western blots were performed, both resulting in a ~100 kDa weak 
band for Dscam in rat microglia and rat brain total protein (Figure 23). This was surprising, 
since rat Dscam protein should be in the range of 222,3 kDa (reported sequence in the NCBI 
database (National Center of Biotechnology Information)) and since the β- actin band was in 
the expected range of 41,7 kDA. 
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Figure 23. Dscam/β-Actin Western Blot of microglia/rat brain protein. 
 
We therefore decided to analyze Dscam protein expression in MG by two additional 
techniques: by immunocytochemical stainings and flow cytometry analysis 
 
2.3. Immunological Stainings 
 
2.3.1. Stainings of brain sections 
 
Our antibody available for these stainings has initially been raised in goats against human 
Dscam, and it has been described to bind to mouse Dscam as well (Fuerst et al., 2008). In a 
first step, we wanted to prove that this antibody is also useful for the detection of rat Dscam. 
For this purpose, we found a weak reactivity of many different neurons and a very strong 
reactivity of neurons in the facial motor nucleus and in the cochlear nucleus (Figure 24, 
adapted from Paxinos and Watson, 2007, and Figure 25). 
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 Figure 24. Facial nuclei (blue) and cochlear nuclei (red) of a rat brain section 
(-2,0 mm interaural, -11,0 mm bregma, adapted from Paxinos and Watson, 
2007). 
 
 
Figure 25. Immunocytochmical staining of brain sections with Dscam. (A) Motor neurons from facial 
nucleus (100X); (B) Neurons from cochlear nucleus (100X); 
 
We did not see Dscam positive cells with this staining procedure, which could indicate 
that these cells express much lower levels of Dscam than neurons. To analyze whether we are 
able to obtain a stronger Dscam reactivity on MG in vitro, I next used mixed glia culture 
monolayers for immunocytochemistry. 
 
 
 
 
 
- 36 - 
 
2.3.2. Stainings of mixed glial cell culture monolayers 
 
These mixed glia culture contain MG on top of an astrocyte/fibroblast feeder layer. To 
unequivocally identify MG, thes cultures were double stained with mouse anti-rat CD11b and 
with goat anti-human Dscam antibody. 
 
 
Figure 26. Dscam/CD11b double staining of mixed glial cell cultures (100X). A CD11b positive cell is 
stained in red. Please note the presence of punctuate, black Dscam reactivity in this cell (arrows). 
 
The number of CD11b/Dscam double positive cells in the total CD11b positive MG pool 
was exceedingly low. Only 3-5 of these double positive cells were found in a 50 mm petri 
dish. 
 
2.3.3. Analysis of pure microglia cells 
 
Parallel to these studies on mixed glia cell culture monolayers, I also analyzed pure 
microglia. I embedded clean shake-off (2nd) microglia cells in low melting agarose and cut the 
block like rat brain into 4 µm sections on a microtome. Microglia cells were stained with Iba1 
and Dscam antibodies. Anti-rat ionized calcium-binding adapter molecule 1 (Iba1) is specific 
for macrophages/microglia (Jones and Tuszynski, 2002). Under these conditions, many 
Dscam/Iba1 double positive cells were found. Approximately 10 % of all Iba1 positive cells 
were also positive for Dscam (Figure 27). 
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 Figure 27. Dscam/Iba1 stainings of cytoblock sections. Iba 1 reactivity is shown in red, Dscam reactivity in 
black. (A) Negative control. (B) -/Iba1. (C) Dscam/-. (D) Dscam/Iba1. (Phase contrast, 100X) 
 
Admittedly, all the data presented so far was rather “soft”: They hinted at an expression of 
Dscam in MG, but were far from convincing. To further improve this, I next tried to enhance 
the sensitivity of detection in FACS analysis. 
 
2.4. Fluorescence associated cell sorting 
 
2.4.1. Dscam flow cytometry 
 
To detect surface expression and intracellular expression of Dscam, the cells were 
analysed in the absence or presence of permeabilization, respectively. Unfortunately, all 9 
FACS analyses performed were essentially negative. I just show one example underneath 
(Figure 28). 
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 Figure 28. Dscam/CD45- Flow cytometry analysis with untreated and permeabilized microglia cells (2nd 
shake-off). Dscam was detected by PE- conjugated donkey anti-goat. All antibodies were incubated for 30 
min at 4°C. The diagram on the top shows that I analyzed a uniform population of CD45 positive MG 
cells. Untreated (1-4) and permeabilized (5-8) cells were investigated with different Dscam antibody 
dilutions: negative control (1, 5), 1:50 (2, 6), 1: 20 (3, 7), 1:4 (4, 8); PE- conjugated donkey anti-goat and 
CD45-FITC were used 1:100; 
 
Since all other attempts to verify protein expression in living cells were unsuccessfull, and 
since we were afraid that these negative results were caused by the usage of an antibody 
which could be suboptimal for the detection of rat Dscam, we decided to use the most 
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sensitive technique of all: a biological read-out for the detection of a functional Dscam in rat 
MG cells. 
 
2.5. Knock down experiment 
 
We decided to study the function of this protein in knock-down experiments, using a 
system based on the Endoporter mediated delivery of morpholinos (see 1.2.6). The procedure 
of this essay is illustrated in Figure 29. 
 
 
Figure 29. Endoporter/Morpholino treatment procedure. 
 
MG attached well after 15 hours, and a roughly constant distribution of morphological 
states developed (Figure 30). Morphological changes were noticed 24 hours after treatment 
with Endoporter and Morpholino (Figure 30). 
 
 
 
- 40 - 
 
Morphological state distribution,
 before treatment with Endoporter
0
10
20
30
40
50
60
70
A B C D E
morphological states
P
er
ce
nt
ag
e 
of
 c
el
ls
 w
ith
 g
iv
en
 
ph
en
ot
yp
e 
[%
]
I
Morphological state distribution,
 after treatment with Endoporter 
0
10
20
30
40
50
60
70
A B C D E
morphological states
P
er
ce
nt
ag
e 
of
 c
el
ls
 w
ith
 g
iv
en
 
ph
en
ot
yp
e 
[%
]
II
 
Figure 30. Cell state distribution before and 24 hours after treatment with Endoporter and Morpholino; 
combined data from two representative studies. (A: dead, B: amoeboid, C: bipolar, D: long-processed, E: 
multipolar) 
 
To give a better overview of these two charts, the proportional change of each 
morphological state due to Endoporter/Morpholino treatment is shown underneath (Figure 
31). 
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Figure 31. Change of morphological cell state distribution from before treatment to 24 hours after 
treatment with Endoporter and Morpholino; combined data from two representative studies. (A: dead, B: 
amoeboid, C: bipolar, D: long-processed, E: multipolar) 
 
Increased numbers of amoeboid cells and decreased numbers of bipolar and multipolar 
cells could be observed by this treatment. Interestingly, the increased population has a 
phagocytic phenotype. 
Since the delivery of Morpholinos by the Endoporter depends on phagocytosis, there was 
the risk that these changes in phenotype were caused by the action of the Endoporter itself. 
Therefore we also tested the action of Endoporter only. We found that Endoporter leads to an 
increase in apoptotic cells, but did not cause an amoeboid phenotype (Figure 32, Figure 33). 
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Figure 32. Cell state distribution before and 24 hours after treatment with Endoporter; combined data 
from two representative studies. Please note that the percentages of cell phenotypes (I) before treatment 
differ to Figure 30 (I), since these experiments were done separately. (A: dead, B: amoeboid, C: bipolar, 
D: long-processed, E: multipolar) 
 
Again, giving a better overview of these two charts, the proportional change of each 
morphological state due to Endoporter treatment is shown underneath (Figure 33). 
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Figure 33. Change of morphological cell state distribution from before treatment to 24 hours after 
treatment with Endoporter; combined data from two representative studies. (A: dead, B: amoeboid, C: 
bipolar, D: long-processed, E: multipolar) 
 
These data clearly indicated that treatment with Endoporter only did not lead to an 
increase in the number of amoeboid MG. 
We wanted to compare the treatment with Endoporter only to the treatment with 
Endoporter plus Dscam Morpholino. For this purpose, we first determined the average 
percentage of untreated cells with a given phenotype from four different experimental setups 
(Figure 34). 
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Figure 34. Averaged numbers of cells with a given phenotype, obtained from four different experimental 
setups. (A: dead, B: amoeboid, C: bipolar, D: long-processed, E: multipolar) 
 
I next subtracted the percentages before treatment from the percentages of the endoporter 
treated cells (Δ1) or from the Endoporter plus Morpholino treated cells (Δ2). To clearly reveal 
the effects of the Dscam Morpholinos, I then subtracted Δ1 from Δ2 (Table 9, Figure 35). 
 
  A B C D E 
before treatment 17,56 28,51 24,62 0,64 28,67 
Endoporter only 39,56 27,48 16,26 0,63 16,08 
Δ1 22,00 -1,03 -8,36 -0,01 -12,59 
before treatment 17,56 28,51 24,62 0,64 28,67 
Endoporter plus Morpholino 11,53 50,59 20,36 0,37 17,15 
Δ2 -6,03 22,08 -4,26 -0,27 -11,52 
Δ2-Δ1 -28,03 23,11 4,10 -0,26 1,08 
Table 9. Percentages of cells with given phenotypes before treatment (averaged) and after treatment with 
Endoporter and with Endoporter plus Dscam Morpholino. Changes (Δ1/2) in percentages of cells with 
given phenotype for Endoporter and Endoporter plus Dscam Morpholino treatment, relating to averaged 
percentages before treatment. The final result, the effect caused by Dscam Morpholino is given by Δ2-Δ1. 
(Phenotypes: dead (A), amoeboid (B), bipolar (C), long-processed (D) and multipolar (E)) 
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Figure 35. Effects of Dscam Morpholino only. Change in percentages of cells with given phenotype from 
before treatment to 24 hours after treatment with Dscam Morpholino, calculated by subtraction of sole 
Endoporter effect from Endoporter/Morpholino treatment; combined data from two Endoporter plus 
Morpholino and two Endoporter studies, relating to averaged cell percentages before treatment of all four 
studies. (A: dead, B: amoeboid, C: bipolar, D: long-processed, E: multipolar) 
 
Dscam morpholinos seem to strongly enhance the formation of an amoeboid (B), and to a 
much lesser extent, also the bipolar (C) and multipolar (E) phenotype of MG. It is also 
important to note that Dscam Morpholinos seem to reduce the numbers of dead cells (A). 
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3. Discussion 
 
Two different microglia populations were described in the rat, based on the expression of 
an antibody-reactive keratan sulfate proteoglycan (KSPG) on their cell surface (Jones and 
Tuszynski, 2002). Its expression rate on MG was quantified in FACS analyses and sorting, 
using the 5D4 monoclonal anti-KSPG antibody. Microarray studies with 5D4 sorted MG, 
resulted in many molecules whose expression rate is upregulated in 5D4high MG, related to 
their 5D4low counterpart (Leitner and Bradl, unpublished observation). We chose five of these 
molecules which were of particular interest, concerning MG development and function: 
Cadm1, Dlx2, Dscam, Tef, and Twist-2. 
At the beginning of my work, we wanted to confirm if all of them were really expressed in 
MG. PCR analysis revealed that four of these five genes were expressed in MG from the 2nd 
shake off: Dlx2, Dscam, Tef, and Twist-2. 
 
Down syndrome cell adhesion molecule (Dscam) is known as phagocytic receptor and as 
an opsonin in Drosophila. Thus, it was the most interesting gene for us. 
Dscam was initially found to be involved in neural development (Yamakawa et al., 1998). 
The Drosophila Dscam gene consists of twenty-four exons, four of them undergoing mutually 
exclusive alternative splicing, generating a potential of 38,016 receptor isoforms (Crayton et 
al., 2006). They are expressed in the nervous and immune system of flies and it has been 
shown that these molecules are functionally required in both systems (Chen et al., 2006). 
Crystallographic analyses revealed a horseshoe-shaped configuration of the Dscam protein 
(see 1.Introduction, Meijers et al., 2007) and either side of the molecule presents a distinct 
surface epitope generated by its hypervariable amino acid residues. Epitope I allows to form a 
homodimer for intrinsic self-recognition, whereas epitope II contributes to heterophilic 
binding, such as netrin or pathogenic molecules (Stuart and Ezekowitz, 2008). An 
unprecendented expansion of complex alternative splicing has been uniquely employed by 
arthropods to generate diverse surface receptors, important for cell-cell communication, 
molecular self recognition in neurons, and innate defenses (Figure 36, Schmucker and Chen, 
2009). 
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 Figure 36. Dscam homophilic and heterophilic interactions for 
signalling, inducing multiple functions (Figure taken from 
Schmucker and Chen, 2009) 
 
Homophilic interactions do not simply result in adhesion but rather constitute a 
recognition event that triggers diverse cellular responses, crucial for neural wiring. Sister- 
dendrites, expressing the same Dscam isoform, prevent from self crossing by Dscam-
dependent repulsion. Dendrites of neighbouring neurons seem to use a Dscam- independent 
process for repulsion (Figure 37, Schmucker, 2007). 
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 Figure 37. Homophilic recognition of identical Dscam isoforms mediates repulsion and 
dendrite self-avoidance. a | Dscam is specifically required for cell-intrinsic recognition. Sister 
dendrites expressing the same isoform are repelled by Dscam-dependent signalling, thereby 
preventing selfcrossing. However, the dendrite–dendrite repulsion of neighbouring neurons 
(that is, dendrite tiling) does not require Dscam function. b | To allow the overlap of dendritic 
fields (tolerance), Dscam repulsion must be blocked. This is achieved by the fact that different 
neurons express different isoforms, which fail to interact homophilically and therefore fail to 
trigger repulsion. c | Multidendritic neurons develop highly branched dendritic branches, but 
none of the branches exhibit self-crossing. A wildtype (Wt) example of a Drosophila 
melanogaster class III peripheral neuron (ddaF) is shown. d | Loss of Dscam in a ddaF neuron 
abolishes self-avoidance, resulting in excessive self-crossing and even abnormal fasciculation of 
dendritic branches (Figure and legend taken from Schmucker, 2007). 
 
In Drosophila, a potential for more than 18,000 isoforms of Dscam on immune-competent 
cells was found. Additionally, a secreted protein isoform was detected in the hemolymph, and 
its loss derogates the efficiency of phagocytosis (Watson et al., 2005). Apparently, many 
functional characteristics are shared by antibodies in mammals and Dscam in Drosophila. 
Both, Dscam on Drosophila haemocytes und B cell receptors (BCRs) on mammalian B cells, 
recognize foreign antigen and transmit signals, leading to cell activation or survival. This 
induces production of opsonin-acting secreted forms of both, Dscam or immunoglobulin 
respectively. In mammals immunoglobulin is bound by Fc receptors, but in Drosophila 
haematocytes it is unclear wether Dscam-opsonized particles are bound by a dedicated 
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receptor or through homotypic interactions with membrane-bound Dscam. Both, BCR and 
Dscam, can also act as endocytic or phagocytic surface receptors to internalize antigens or 
pathogens (Figure 38, Stuart and Ezekowitz, 2008). 
 
 
 
Figure 38. Insect Dscam and mammalian immunoglobulins show common functional 
characteristics: recognition/binding of foreign antigen, followed by activation of cells (or 
survival) and production of opsonin-acting secreted molecules; additionally, both can 
also act as cell surface bound phagocytic/endocytic receptor; (Figure taken from Stuart 
and Ezekowitz, 2008). 
 
 
It might be possible that Dscam, similar to many chemokines has both, a neuronal and a 
immunological relevance in mammals. Chemokines, which regulate diverse functions in the 
immune system, were initially thought to play a role in leukocyte migration and 
neuroinflammation. Later, they were found to be expressed by all major cell types in the CNS. 
Interestingly, CCR2, a chemokine receptor that binds to both CCL2 and CCL7, is expressed 
by neurons and glia in the adult rat brain (Edman et al., 2008). Another chemokine,  58 
CXCL12 was initially reported as a bone marrow stromal cell-derived chemoattractant and 
proliferative factor for B cell precursors. More recently, studies have demonstrated the roles 
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of CXCL12, and its receptor, CXCR4, in multiple aspects of B and T cell development and in 
effector immune responses. CXCL12 was found to be constitutively expressed by a variety of 
parenchymal tissues, including the CNS where it participates in neuronal proliferation, 
migration, axonal pathfinding, and myelination during development. 
 
PCR analysis with Dscam_middle, representing the C-terminal, intracellular part of the 
Dscam protein, showed the presence of its mRNA in microglia from the 2nd shake off and in 
sorted microglia (CD45low) from healthy and PLP transgenic rat spinal cords, whereas 
macrophages from peritoneum and sorted macrophages (CD45high) from spinal cord and 
spleen appeared to be Dscam negative. Products from the N- termius of Dscam, using the 
Dscam_large primers, were also obtained from microglia from the 2nd shake off. 
 
Further, we wanted to investigate the protein level of Dscam. We did a Western blot 
analysis and expected a band in the range of 222,3 kDa (reported sequence in the NCBI 
database (National Center of Biotechnology Information)). Both trials yielded an unexpected 
band at ~ 100 kDa for both, protein from rat microglia from the 2nd shake off and from rat 
brain (as control) (see 2.2.). Immuncytochemical stainings resulted in Dscam positive cells, 
but since these results were not convincing enough, we wanted to confirm our findings with 
FACS analysis. Unfortunately, we were not able to obtain clean Dscam positive and negative 
populations with our Dscam antibody in FACS analysis (2.4.1).  
A possible reason for our findings could be that our available antibody, goat anti-human 
Dscam, was not suitable for our purposes. An unknown splice variant could explain the 
smallish band we had observed. But it is more likely that the antibody bound to another rat 
protein which had a high sequence homology to human Dscam. 
Otherwise, low signals, received in Western blot analysis and immuncytochemical 
stainings, maybe showed up owing to an impurity of our samples due to neuronal 
contaminants. FACS sorts with just 1-2% impurity of non-target cells, which highly express 
Dscam, may lead to signals in microarray studies and even in PCR. 
 
Finally, we performed a functional knock down experiment in cultured MG, based on an 
Endoporter mediated endocytosis of Dscam Morpholinos. Unfortunately, we were not able to 
prove that we achieved a successful knock down with our protein analysis methods. 
Nevertheless, we revealed an interesting effect of the Dscam Morpholino treatment: The 
formation of amoeboid MG seemed to be strongly enhanced. MG of this phenotype are 
- 51 - 
 
known to be activated phagocytes (Ling, 1976). Nonoverlapping coverage of receptive 
territories is ensured by cell-specific repulsive interactions in the development of neuron 
arbors and there is strong evidence that Dscam mediates this contact-dependent process 
(Matthews et al., 2007). Based on this knowledge and assumed that Dscam is expressed in 
MG, one would suppose that MG would loose their ability to cover non-overlapping 
territories due to Dscam knock down. Hence, we speculate that Dscam could mediate this 
MG- typic process to cover non-overlapping territories. As this is the case, knock down of 
this gene could lead to a loss of their ability to form processes and they would develop the 
phagocytic phenotype. 
 
Future experiments should be done to gain more information about the role of Dscam in 
mammals. A rat specific anti-Dscam antibody would help to propose clear statements about 
Dscam expression in rat MG. Additionally, novel fundamental knowledge about the diversity 
of MG populations could lead to new therapeutic approaches. 
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